Compound information
- Natural Products
- ZC2090080
- Molecular Formula
- C16H17NO2
- Molecular Weight
- 255.125928784 g/mol
- Structure
-
- IUPAC Name
- benzyl N-[(1R)-1-phenylethyl]carbamate
- InChI
- InChI=1S/C16H17NO2/c1-13(15-10-6-3-7-11-15)17-16(18)19-12-14-8-4-2-5-9-14/h2-11,13H,12H2,1H3,(H,17,18)/t13-/m1/s1
- InChI Key
- XFSAQXHAIMAZTD-CYBMUJFWSA-N
- SMILES
- C[C@@H](NC(=O)OCc1ccccc1)c1ccccc1
- Source
- ZINC000000478178
Warheads
- Carbamate
-
ADMET Property
Physicochemical Property
Property | Value | Property | Value |
---|---|---|---|
Heavy Atom Count | 19 | Ring Count | 2 |
Heteroatom Count | 3 | Rotatable Bond Count | 4 |
Hydrogen Bond Acceptor Count | 2 | Hydrogen Bond Donor Count | 1 |
Topological Polar Surface Area | 38.33 Å2 | LogP | 3.324 |
LogS | -3.706 | LogD | 3.544 |
Absorption
Property | Value | Property | Value |
---|---|---|---|
Pgp inhibitor | 0.051 | Pgp substrate | 0.014 |
HIA | 0.964 | F20 % | 0.995 |
F30 % | 0.573 | Caco-2 | -4.432 |
MDCK | -4.566 |
Distribution
Property | Value | Property | Value |
---|---|---|---|
BBB Penetration | 0.38 | PPB | 92.409 |
VD | 0.439 | Fu | 1.282 |
Metabolism
Property | Value | Property | Value |
---|---|---|---|
CYP1A2 inhibitor | 0.999 | CYP1A2 substrate | 0.81 |
CYP2A6 substrate | 0.768 | CYP2B6 substrate | 0.717 |
CYP2C19 inhibitor | 0.889 | CYP2C19 substrate | 0.861 |
CYP2C8 substrate | 0.832 | CYP2C9 inhibitor | 0.926 |
CYP2C9 substrate | 1.0 | CYP2D6 inhibitor | 0.826 |
CYP2D6 substrate | 0.969 | CYP2E1 substrate | 0.643 |
CYP3A4 inhibitor | 0.746 | CYP3A4 substrate | 0.997 |
Excretion
Property | Value | Property | Value |
---|---|---|---|
T1/2 | 0.458 | CL | 4.948 |
Toxicity
Property | Value | Property | Value |
---|---|---|---|
hERG Blockers | 0.099 | Hepatotoxicity | 0.856 |
Mutagenicity | 0.518 | Rat Oral Acute Toxicity | 0.051 |
FDAMDD | 0.711 | Skin Sensitization | 0.06 |
Carcinogenicity | 0.195 | Eye Corrosion | 0.004 |
Eye Irritation | 0.076 | Respiratory Toxicity | 0.161 |
Environmental Toxicity
Property | Value | Property | Value |
---|---|---|---|
Bioconcentration Factors | 0.96 | IGC50 | 3.904 |
LC50FM | 3.875 | LC50DM | 6.008 |
Tox21 Pathway
Property | Value | Property | Value |
---|---|---|---|
NR-AR | 0.136 | NR-AR-LBD | 0.179 |
NR-AhR | 0.003 | NR-Aromatase | 0.037 |
NR-ER | 0.272 | NR-ER-LBD | 0.301 |
NR-PPAR-gamma | 0.236 | SR-ARE | 0.037 |
SR-ATAD5 | 0.372 | SR-HSE | 0.121 |
SR-MMP | 0.015 | SR-p53 | 0.012 |
Similar covalent inhibitors
Similar covalent drugs
No similar covalent drugs found for this compound.